4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
June 07, 2022 08:30 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia – 4BIO Capital...
4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics
April 20, 2021 09:00 ET
|
4Bio Capital
Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...